---
title: "How Nanobiotix Got Wall Street's Attention By Using Physics To Battle Cancer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287076168.md"
description: "Nanobiotix aims to revolutionize a long-standing cancer treatment method with innovative physics-based approaches. This leading biotech stock has seen significant growth, capturing the attention of Wall Street."
datetime: "2026-05-20T13:17:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287076168.md)
  - [en](https://longbridge.com/en/news/287076168.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287076168.md)
---

# How Nanobiotix Got Wall Street's Attention By Using Physics To Battle Cancer

Nanobiotix aims to revolutionize a long-standing cancer treatment method with innovative physics-based approaches. This leading biotech stock has seen significant growth, capturing the attention of Wall Street.

### Related Stocks

- [NBTX.US](https://longbridge.com/en/quote/NBTX.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [Nanobiotix Reports Promising Phase 2 Data for NBTXR3 in Stage 3 Inoperable Lung Cancer](https://longbridge.com/en/news/286776980.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug](https://longbridge.com/en/news/286394551.md)
- [08:00 ETAvance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership](https://longbridge.com/en/news/286094661.md)
- [Analyst Reaffirms Buy on PAVmed, Citing Oncology Platform Momentum and Partnerships; Price Target Maintained at $16](https://longbridge.com/en/news/286945953.md)